[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chronic-traumatic-encephalopathy":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":35,"states":36},"Chronic traumatic encephalopathy",4,3,[8,15,22,28],{"nct_id":9,"title":10,"phases":11,"status":12,"updated_at":13,"content_modified":14},"NCT02795052","Neurologic Stem Cell Treatment Study",[],"RECRUITING","2026-08-26T02:15:11.740957Z","2026-04-29T02:57:57.086071Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06254469","Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease",[19],"Phase 3","2026-08-26T02:16:11.347936Z","2026-05-05T02:43:29.361869Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT04124029","Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)",[],"2026-08-26T02:18:59.761994Z","2026-05-13T02:55:06.243070Z",{"nct_id":29,"title":30,"phases":31,"status":32,"updated_at":33,"content_modified":34},"NCT06860828","The DIAGNOSE CTE Research Project-II",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:30.961790Z","2026-06-16T05:54:07.839726Z",[],[]]